4.5 Review

Meta-analysis of peripheral insulin-like growth factor 1 levels in schizophrenia

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Psychiatry

Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug na?ve first-episode schizophrenia

Dachun Chen et al.

Summary: This study showed that serum levels of IL-17 and IGF-1 in schizophrenia patients were significantly higher than in normal individuals, with IGF-1 levels decreasing after treatment while IL-17 levels remained stable. Furthermore, the baseline IGF-1 levels were negatively associated with improvements in negative symptoms of schizophrenia, suggesting a potential role of IGF-1 in the pathophysiology of negative symptoms in schizophrenia.

PSYCHIATRY RESEARCH (2021)

Article Psychiatry

Association Between Serum Insulin-Like Growth Factor 1 Levels and the Clinical Symptoms of Chronic Schizophrenia: Preliminary Findings

Naomichi Okamoto et al.

Summary: This study found no significant difference in serum IGF-1 levels between patients with chronic schizophrenia and healthy controls. Serum IGF-1 levels were significantly negatively correlated with PANSS total and general scores, and were associated with patient age.

FRONTIERS IN PSYCHIATRY (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Biochemistry & Molecular Biology

Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer

Aldona Kasprzak

Summary: Colorectal cancer is a common aggressive carcinoma with poor prognosis, often associated with metabolic syndrome and high blood sugar levels. The role of IGF-1 in glucose metabolism in colorectal carcinogenesis and its potential link to the Warburg effect require further investigation. Current therapeutic strategies targeting impaired glucose metabolism in CRC are being explored to improve treatment outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Psychiatry

Evaluation of IGF-1 as a novel theranostic biomarker for schizophrenia

Umit Haluk Yesilkaya et al.

Summary: The study found that fasting blood glucose levels were higher in schizophrenia patients compared to healthy controls, and LDL levels were higher in treatment sensitive patients than in treatment resistant patients but not significantly different from healthy controls. IGF-1 levels were significantly associated with treatment resistance and age of disease onset.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

Article Health Care Sciences & Services

Measuring IGF-1 and IGFBP-3 Profiles in Women Seeking Assisted Reproduction; Relationship to Clinical Parameters (Study 1)

John L. Yovich et al.

JOURNAL OF PERSONALIZED MEDICINE (2020)

Review Medicine, General & Internal

Schizophrenia

Stephen R. Marder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Psychiatry

Social cognition in the course of psychosis and its correlation with biomarkers in a male cohort

Evangelos Ntouros et al.

COGNITIVE NEUROPSYCHIATRY (2018)

Review Biochemistry & Molecular Biology

New Targets for Schizophrenia Treatment beyond the Dopamine Hypothesis

Albert C. Yang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)

Article Mathematical & Computational Biology

Introduction, comparison, and validation of Meta-Essentials: A free and simple tool for meta-analysis

Robert Suurmond et al.

RESEARCH SYNTHESIS METHODS (2017)

Article Psychiatry

Relationships between IGF-1, schizophrenia, and treatment of metabolic syndrome

Aysegul Demirel et al.

COMPREHENSIVE PSYCHIATRY (2014)

Article Clinical Neurology

Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients

Aitor Palomino et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)

Review Cell Biology

The current status of IGF-I assays - A 2009 update

Jan Frystyk et al.

GROWTH HORMONE & IGF RESEARCH (2010)

Letter Genetics & Heredity

Polymorphic CA repeat in IGF-I gene: lack of association with schizophrenia

Cristian Bonvicini et al.

PSYCHIATRIC GENETICS (2010)

Article Psychiatry

Insulin and insulin-like growth factor-1 abnormalities in anti psychotic-naive schizophrenia

Ganesan Venkatasubramanian et al.

AMERICAN JOURNAL OF PSYCHIATRY (2007)

Article Genetics & Heredity

IGF1, growth pathway polymorphisms and schizophrenia: A pooling study

D. Gunnell et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2007)

Article Medical Laboratory Technology

Associations of blood levels of insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-3 in schizophrenic Arab subjects

Abayomi O. Akanji et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)

Article Psychology, Clinical

The effect of clozapine on factors controlling glucose homeostasis

OD Howes et al.

JOURNAL OF CLINICAL PSYCHIATRY (2004)

Article Medicine, General & Internal

Meta-analysis of observational studies in epidemiology - A proposal for reporting

DF Stroup et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)